Study summary
A once-weekly insulin with fixed doses worked as well as daily insulin
2dose changes needed in a year, vs 8 with daily glargine (median)
What was tested
Efsitora, a once-weekly basal insulin given at four fixed dose steps, against daily insulin glargine in people starting insulin.
What they found
- HbA1c fell to 7.05% vs 7.08%, showing efsitora was no worse.
- Serious low blood sugar was less frequent (0.50 vs 0.88 events per person-year).
- Median dose adjustments were 2 vs 8.
What it means
Weekly insulin could make starting insulin simpler.
Last reviewed 2026-11-16 by the Find a Trial editorial team.
Information on this page is for educational purposes and is not medical advice.
Always consult qualified healthcare professionals about clinical trial participation.